Patent · US Active

Sustained-release formulation

US8551522B2 · kind B2 · utility

0Cited by
12References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 5, 2008
Grant dateOct 8, 2013
Priority date
Expiry dateNov 10, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P37/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A sustained-release formulation is provided comprising a solid dispersion composition comprising a tricyclic compound or a pharmaceutically acceptable salt thereof in a mixture comprising a water-soluble polymer and a water-insoluble polymer, and an excipient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.